Bleed risk 'outweighs benefits of aspirin' in prevention of CV events

The best strategy may be to simply prescribe a statin instead, says researcher

Three major trials of aspirin for primary prevention of cardiovascular events, viewed together, suggest its benefits are largely outweighed by the bleeding risk, a leading Harvard specialist says.